FLT3
Summary: This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. This receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia. [provided by RefSeq, Jan 2015].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
fms related tyrosine kinase 3 | MIM:136351 | Ensembl:ENSG00000122025 | HGNC:HGNC:3765 | PA28181 | 13q12.2 |
GO terms in FLT3
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IBA | GO:0004709 | MAP kinase kinase kinase activity |
MF | IBA | GO:0004713 | protein tyrosine kinase activity |
MF | IBA | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
MF | TAS | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
MF | IBA | GO:0004888 | transmembrane signaling receptor activity |
MF | ISS | GO:0004896 | cytokine receptor activity |
MF | TAS | GO:0005021 | vascular endothelial growth factor-activated receptor activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
MF | IBA | GO:0019838 | growth factor binding |
MF | IBA | GO:0031434 | mitogen-activated protein kinase kinase binding |
MF | IEA | GO:0035259 | glucocorticoid receptor binding |
MF | TAS | GO:0042803 | protein homodimerization activity |
MF | IMP | GO:0043621 | protein self-association |
MF | IEA | GO:0044877 | protein-containing complex binding |
CC | IEA | GO:0005634 | nucleus |
CC | IBA | GO:0005737 | cytoplasm |
CC | IDA | GO:0005783 | endoplasmic reticulum |
CC | IEA | GO:0005788 | endoplasmic reticulum lumen |
CC | IEA | GO:0005829 | cytosol |
CC | TAS | GO:0005886 | plasma membrane |
CC | IBA | GO:0005887 | integral component of plasma membrane |
CC | TAS | GO:0005887 | integral component of plasma membrane |
CC | IEA | GO:0032991 | protein-containing complex |
CC | IBA | GO:0043235 | receptor complex |
BP | ISS | GO:0001776 | leukocyte homeostasis |
BP | ISS | GO:0002318 | myeloid progenitor cell differentiation |
BP | ISS | GO:0002328 | pro-B cell differentiation |
BP | TAS | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway |
BP | IBA | GO:0007275 | multicellular organism development |
BP | TAS | GO:0008284 | positive regulation of cell proliferation |
BP | IBA | GO:0009968 | negative regulation of signal transduction |
BP | IEA | GO:0010243 | response to organonitrogen compound |
BP | TAS | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling |
BP | TAS | GO:0018108 | peptidyl-tyrosine phosphorylation |
BP | ISS | GO:0019221 | cytokine-mediated signaling pathway |
BP | TAS | GO:0019221 | cytokine-mediated signaling pathway |
BP | IDA | GO:0030097 | hemopoiesis |
BP | IBA | GO:0030154 | cell differentiation |
BP | ISS | GO:0030183 | B cell differentiation |
BP | IEA | GO:0031100 | animal organ regeneration |
BP | IBA | GO:0033674 | positive regulation of kinase activity |
BP | ISS | GO:0035726 | common myeloid progenitor cell proliferation |
BP | IEA | GO:0038084 | vascular endothelial growth factor signaling pathway |
BP | TAS | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein |
BP | TAS | GO:0042981 | regulation of apoptotic process |
BP | IBA | GO:0043066 | negative regulation of apoptotic process |
BP | TAS | GO:0043406 | positive regulation of MAP kinase activity |
BP | IBA | GO:0043410 | positive regulation of MAPK cascade |
BP | TAS | GO:0043410 | positive regulation of MAPK cascade |
BP | TAS | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity |
BP | ISS | GO:0046651 | lymphocyte proliferation |
BP | TAS | GO:0046777 | protein autophosphorylation |
BP | IBA | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
BP | ISS | GO:0071345 | cellular response to cytokine stimulus |
BP | TAS | GO:0071345 | cellular response to cytokine stimulus |
BP | IEA | GO:0071385 | cellular response to glucocorticoid stimulus |
BP | ISS | GO:0097028 | dendritic cell differentiation |
Gene expression in normal tissue: FLT3
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in FLT3
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-109704 | PI3K Cascade |
reactome | R-HSA-112399 | IRS-mediated signalling |
reactome | R-HSA-1280215 | Cytokine Signaling in Immune system |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) |
reactome | R-HSA-2428924 | IGF1R signaling cascade |
reactome | R-HSA-2428928 | IRS-related events triggered by IGF1R |
reactome | R-HSA-449147 | Signaling by Interleukins |
reactome | R-HSA-449836 | Other interleukin signaling |
reactome | R-HSA-5673001 | RAF/MAP kinase cascade |
reactome | R-HSA-5683057 | MAPK family signaling cascades |
reactome | R-HSA-5684996 | MAPK1/MAPK3 signaling |
reactome | R-HSA-74751 | Insulin receptor signalling cascade |
reactome | R-HSA-74752 | Signaling by Insulin receptor |
reactome | R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
wikipathways | WP3657 | Hematopoietic Stem Cell Gene Regulation by GABP alpha-beta Complex |
wikipathways | WP3658 | Wnt-beta-catenin Signaling Pathway in Leukemia |
wikipathways | WP4172 | PI3K-Akt Signaling Pathway |
wikipathways | WP4223 | Ras Signaling |
kegg | hsa04010 | MAPK signaling pathway - Homo sapiens (human) |
kegg | hsa04014 | Ras signaling pathway - Homo sapiens (human) |
kegg | hsa04060 | Cytokine-cytokine receptor interaction - Homo sapiens (human) |
kegg | hsa04151 | PI3K-Akt signaling pathway - Homo sapiens (human) |
kegg | hsa04640 | Hematopoietic cell lineage - Homo sapiens (human) |
kegg | hsa05200 | Pathways in cancer - Homo sapiens (human) |
kegg | hsa05202 | Transcriptional misregulation in cancer - Homo sapiens (human) |
kegg | hsa05221 | Acute myeloid leukemia - Homo sapiens (human) |
kegg | hsa05230 | Central carbon metabolism in cancer - Homo sapiens (human) |
pharmgkb | PA165959425 | Pathway_PA165959425 |
pharmgkb | PA165959584 | Sorafenib Pharmacodynamics |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD332 | A-770041 | 1 |
iGMDRD60 | Quinoclamine | 2 |
iGMDRD677 | ABT-199 (GDC-0199) | 1 |
iGMDRD138 | PX 12 | 1 |
iGMDRD491 | TAE-684 | 1 |
iGMDRD913 | FLT3 inhibitor | 2 |
iGMDRD413 | Crenolanib | 2 |
iGMDRD134 | Sorafenib | 22 |
iGMDRD318 | PAC-1 | 2 |
iGMDRD440 | Nutlin-3A | 1 |
iGMDRD885 | Compound 110 | 2 |
iGMDRD388 | YM201636 | 1 |
iGMDRD446 | LY 2183240 | 1 |
iGMDRD498 | GW441756X | 1 |
iGMDRD163 | all trans Retinoic Acid | 1 |
iGMDRD297 | Austocystin D | 2 |
iGMDRD378 | ZM-447439 | 2 |
iGMDRD1008 | SR-II-138A | 2 |
iGMDRD144 | NSC95397 | 2 |
iGMDRD354 | Midostaurin | 6 |
iGMDRD3 | PD-173074 | 1 |
iGMDRD269 | Purmorphamine | 3 |
iGMDRD472 | PF-562271 | 1 |
iGMDRD505 | Pevonedistat | 2 |
iGMDRD556 | Quizartinib | 24 |
iGMDRD56 | Azacitidine | 2 |
iGMDRD515 | Staurosporine | 2 |
iGMDRD434 | BMS-536924 | 2 |
iGMDRD241 | Sunitinib | 5 |
iGMDRD481 | Dactolisib | 1 |
iGMDRD267 | Oligomycin A | 1 |
iGMDRD551 | Ponatinib | 6 |
iGMDRD177 | Teniposide | 3 |
iGMDRD382 | CEP-701 | 2 |
iGMDRD307 | Manumycin A | 2 |
iGMDRD125 | BIRB-796 | 1 |
iGMDRD116 | CD437 | 2 |
iGMDRD424 | Tamatinib | 2 |
iGMDRD188 | Piperlongumine | 2 |
iGMDRD4 | AG-1296 | 1 |
iGMDRD399 | Selumetinib | 4 |
iGMDRD23 | Gossypol | 3 |
iGMDRD568 | SCHEMBL15005512 | 1 |
iGMDRD493 | GSK269962A | 1 |
iGMDRD294 | Batimastat | 3 |
iGMDRD394 | BX-795 | 1 |
iGMDRD694 | HG6-64-1 | 1 |
iGMDRD126 | Tipifarnib | 1 |
iGMDRD1034 | WZ3105 | 1 |
iGMDRD433 | Lexibulin | 3 |
iGMDRD571 | Cabozantinib | 2 |
iGMDRD443 | Linifanib | 1 |
iGMDRD654 | SL 0101-1 | 1 |
iGMDRD476 | WH-4-023 | 1 |
iGMDRD329 | Merck60 | 5 |
iGMDRD421 | AZD7762 | 2 |
iGMDRD158 | NSC141540 | 2 |
iGMDRD202 | Curcumin | 6 |
iGMDRD705 | Nakiterpiosin | 2 |
iGMDRD77 | Itraconazole | 2 |
iGMDRD65 | Daunorubicin | 2 |
iGMDRD564 | GSK-650394 | 1 |
iGMDRD961 | novel FLT3 inhibitor | 2 |
iGMDRD315 | SU-5614 | 2 |
iGMDRD162 | All-trans Retinoic Acid | 2 |
iGMDRD111 | Lestaurtinib | 2 |
iGMDRD523 | Cyanoquinoline, 11 | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in FLT3